Jonathan D Miller, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 323 E Riverside Dr, Eagle, ID 83616 Phone: 208-367-5300 Fax: 208-367-2692 |
News Archive
Zhihao Zhuang, assistant professor in the Department of Chemistry and Biochemistry at the University of Delaware, has won the National Science Foundation Faculty Early Career Development Award.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
There isn't a one-size-fits-all approach when choosing the right footwear or inner sole to take away pressure from diabetic patients' feet. The body mass index (BMI) of diabetics indicates how stiff or soft the cushioning material in shoes should be.
Fibrex Medical has announced positive Phase II results for FX06, a peptide for the treatment of reperfusion injury - the damage to heart muscle that results from remedial treatment following a heart attack. The results will be presented at the ESC Congress today in Munich, Germany.
The Institute for Health Technology Studies (InHealth) has awarded a grant totaling more than $238,000 to a research team at the Helen & Harry Gray Cancer Center at Hartford Hospital in Connecticut to study how various prostate cancer treatments affect a patient's "social capital" the ability to continue working productively in a paying job.
› Verified 2 days ago